Vicryl Rapide
by Johnson & Johnson International 88 variants
Ref V4930HModel Vicryl Rapide
Active
CE MDR
Valid until
19 Dec 2027
FDA recalls
Not applicable
Documents
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR | NumberMDR 730044 | Date10 Sep 2026 | StatusActive |
Certificates
- MDR 730044 Active
Technical documentation EU MDR
- Certifier
- BSI Group The Netherlands B.V. 2797
- Issued
- 10 Sep 2026
- Expires
- 19 Dec 2027
- Reason
- Change approved
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/MDR Active
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czechia
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
- Türkiye
Specification
- Device Name
- VICRYL RAPIDE (Polyglactin 910) Synthetic Absorbable Suture
- Model / Reference
- Vicryl Rapide, V4930H
- Primary DI / UDI-DI
- 10705031108233
- Basic UDI-DI
- 0705031a012094L
- EMDN Code
- H010101020201, H010101020202
- Device Class
- Class III
- EU market of registration
- Belgium
Manufacturer details
- EUDAMED SRN
- BE-MF-000008018
Other devices from Johnson & Johnson International
Properties
Other properties (11)
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- CMR Substance: No
- Human-derived: No
- Human Tissues: No
- Animal Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No
- Incorporates Medicinal Product: No